2025-12-21 - Analysis Report
Okay, here's a breakdown of the Exxon Mobil (XOM) data provided, followed by a comprehensive analysis.

**1. Performance Comparison (XOM vs. VOO)**

*   **XOM:** Exxon Mobil Corp - One of the world's largest publicly traded international oil and gas companies.
*   **XOM Cumulative Return:** 21.17%
*   **VOO (S&P 500) Cumulative Return:** 100.88%
*   **Divergence:** -80.7 (Relative Divergence: 15.0)

    *   **Analysis:**  XOM has significantly underperformed the S&P 500 (VOO) over the period examined. The current divergence of -80.7% indicates a substantial difference in cumulative returns. A relative divergence of 15.0 suggests that the underperformance, while large, is not at its historical worst based on the provided min/max range.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha  | Beta   | Cap(B) |
|------------|--------|--------|--------|--------|--------|
| 2015-2017  | 9.0%   | 65.6%  | -19.0% | 0.0    | 356.6  |
| 2016-2018  | -5.0%  | 71.1%  | -21.0% | 0.1    | 290.7  |
| 2017-2019  | -6.0%  | 71.1%  | -28.0% | -0.5   | 297.5  |
| 2018-2020  | -34.0% | 78.8%  | -57.0% | -0.4   | 175.7  |
| 2019-2021  | -3.0%  | 78.8%  | -49.0% | -0.9   | 260.9  |
| 2020-2022  | 48.0%  | 81.8%  | 48.0%  | -0.1   | 470.2  |
| 2021-2023  | 39.0%  | 81.8%  | 37.0%  | 0.5    | 426.2  |
| 2022-2024  | 7.0%   | 81.8%  | -13.0% | 0.8    | 458.6  |
| 2023-2025  | -17.0% | 77.7%  | -82.0% | 1.2    | 497.5  |

*   **CAGR:** Fluctuates significantly, reflecting volatility.
*   **MDD:** High Maximum Drawdown indicates substantial risk.
*   **Alpha:**  Negative alpha dominates, meaning XOM has generally underperformed its expected return based on its risk (Beta). Recent years show some positive alpha but are followed by large negative Alpha (2023-2025).
*   **Beta:** Generally low Beta values suggest the XOM is less sensitive to the market movement as a whole, than the market average (1).
*   **Cap(B):** Market capitalization has fluctuated over the years.

**2. Recent Stock Price Movement**

*   **Current Price:** 116.69
*   **Previous Close:** 116.54
*   **Change:** 0.13
*   **5-day SMA:** 116.62
*   **20-day SMA:** 116.86
*   **60-day SMA:** 115.47

    *   **Analysis:** The current price is slightly above the 5-day and 60-day SMA but below the 20-day SMA. The small change from the previous close suggests minimal recent price movement.

**3. Indicators Analysis**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment)
*   **RSI:** 54.45 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.16 (Slightly negative - suggesting short-term weakness)
*   **Hybrid Signal:** Cash_0%_Buy 90% of cash (8 shares - Safe - MRI:0.80)
*   **Recent (20 days) Relative Divergence Change:** -2.2 (Negative - short-term decline)
*   **Expected Return (%):** -162.3%

    *   **Analysis:** The MRI suggests a medium level of investment risk. The RSI is neutral.  The negative PPO and recent divergence change point to potential short-term weakness.  The Hybrid signal indicates a buy recommendation.  The extremely negative expected return is a significant concern.

**4. Recent News & Significant Events**

*   **Rating Downgrade:** Seeking Alpha article highlights a rating downgrade and concerns about stock performance ("Going Nowhere").
*   **Institutional Selling:** Peoples Bank KS lowered its position in XOM.
*   **2030 Plan Upgrade/Analyst Forecasts:**  Reports mention an upgraded 2030 profit outlook and analyst forecasts, potentially due to cost cutting rather than higher revenue.
*   **Dividend Streak:**  Yahoo Finance highlights ExxonMobil's long dividend streak, but this is a backward looking metric.
*   **Stock Down 3%:** Quiver Quantitative notes a recent decline.
*   **2030 Profit Outlook:** Simplywall.st analyzes if upgraded profit outlook alters the investment case.

    *   **Analysis:** Recent news is mixed. While some articles focus on long-term plans and dividends, the rating downgrade, institutional selling, and recent price decline are negative signals.

**4-2. Analyst Opinions**

*   **Consensus:** ~Buy (2.22)
*   **Target Price (avg/high/low):** 131.56 / 158.00 / 109.00
*   **Recent Rating Changes:** No recent changes provided.

    *   **Analysis:** Despite the negative news and underperformance, analysts generally have a "Buy" consensus with a target price significantly above the current price. However, the lack of detail about recent rating changes makes it difficult to assess the strength of this consensus.

**5. Comprehensive Analysis & Summary**

Exxon Mobil (XOM) is currently presenting a mixed investment picture.

*   **Negative Signals:**
    *   **Significant Underperformance:** XOM has substantially underperformed the S&P 500.
    *   **High Drawdown:** High historical Maximum Drawdown indicates substantial risk in investing in XOM
    *   **Negative Alpha:** Underperforming expectations relative to its risk.
    *   **Negative Expected Return:** The projected -162.3% return is a major red flag, suggesting significant downside risk based on the model.
    *   **Recent Downgrade:** Analyst concerns about future stock performance.
    *   **Institutional Selling:**  Indicates a lack of confidence from some investors.
    *   **Short-term Weakness:**  Negative PPO and recent divergence change point to potential further declines.

*   **Positive Signals:**
    *   **Analyst Buy Consensus:**  Analysts generally rate the stock as a "Buy."
    *   **Long Dividend Streak:**  A history of consistent dividend payments (though this is historical).
    *   **MRI:0.7:** Hybrid Signal indicate medium level of investment risk.

*   **Overall Assessment:**

The significant underperformance, negative expected return, and recent downgrade suggest caution. While analysts have a "Buy" consensus, the lack of recent positive catalysts and concerning indicators warrant a careful approach. It is important to consider if analyst target price is based on updated and accurate revenue outlooks vs cost cutting (which can't go on forever). It's worth investigating the reasoning behind the analyst consensus and whether they have factored in the specific risks highlighted in the news and indicators.

**Disclaimer:** This analysis is based on the provided data and should not be considered financial advice.  Conduct thorough research and consult with a qualified financial advisor before making any investment decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.